Evidence map›Paper›PMID 32515813›Full record

SynthesisJAMA2020

Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis.

Brooke Levis, Ying Sun, Chen He, Yin Wu, Ankur Krishnan, Parash Mani Bhandari, Dipika Neupane, Mahrukh Imran, Eliana Brehaut, Zelalem Negeri and 134 more

3 registry-linked trialsOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 315 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
315citing papers in PubMed, 5 pooled it
42.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05429619 completednot on this mapstarted 2023, after this paper: background citation

Advancing Peer Support Programming to Address PTSD and Trauma Among Canadian Public Safety Personnel and Veterans

TypeobservationalSponsorMcMaster UniversityRan2023 to 2024Enrolled950ConditionsMental Health Issue, Mental Stress, Post Traumatic Stress DisorderArmsPeerOnCall
NCT06164457 narecruitingnot on this mapstarted 2024, after this paper: background citation

Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease: a Pilot Study

TypeinterventionalSponsorUniversity of CalgaryRan2024 to 2027Enrolled200ConditionsCoronary Artery Disease, Patient Acceptance of Health Care, Physician-Patient RelationsArmsePROM Survey
NCT07073144 nacompletednot on this mapstarted 2025, after this paper: background citation

The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment

TypeinterventionalSponsorThe Hong Kong Polytechnic UniversityRan2025 to 2025Enrolled24ConditionsSevere Mobility Impairment, Spinal Cord Injuries (Complete and Incomplete), PoliomyelitisArmsVirtual walking, Passive observing walking
3 · Its place in the literature

Who cites it

315 citing papers in PubMed, 5 syntheses or guidelines pooled it, 524 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Evaluating a program to prevent anxiety in children of anxious parents: a randomized controlled trial.Journal of child psychology and psychiatry, and allied disciplines · 2025
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparative performance of the EQ-5D-5L, EQ-HWB, and PROMIS-10 in screening for history of anxiety and depression in the general adult population in 15 countries.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

255 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

144 authors at 3 institutions in 2 countries.

Brooke LevisLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Ying SunLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Chen HeLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Yin WuLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Ankur KrishnanLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Parash Mani BhandariLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Dipika NeupaneLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Mahrukh ImranLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Eliana BrehautLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Zelalem NegeriLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Felix H FischerCenter for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité, Universitätsmedizin Berlin, Germany.
Andrea BenedettiDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
Depression Screening Data (DEPRESSD) PHQ Collaboration
Liying Che
Alexander Levis
Kira Riehm
Nazanin Saadat
Marleine Azar
Danielle Rice
Jill Boruff
Lorie Kloda
Pim Cuijpers
Simon Gilbody
John Ioannidis
Dean McMillan
Scott Patten
Ian Shrier
Roy Ziegelstein
Ainsley Moore
Dickens Akena
Dagmar Amtmann
Bruce Arroll
Liat Ayalon
Hamid Baradaran
Anna Beraldi
Charles Bernstein
Arvin Bhana
Charles Bombardier
Ryna Imma Buji
Peter Butterworth
Gregory Carter
Marcos Chagas
Juliana Chan
Lai Fong Chan
Dixon Chibanda
Rushina Cholera
Kerrie Clover
Aaron Conway
Yeates Conwell
Federico Daray
Janneke de Man-van Ginkel
Jaime Delgadillo
Crisanto Diez-Quevedo
Jesse Fann
Sally Field
Jane Fisher
Daniel Fung
Emily Garman
Bizu Gelaye
Leila Gholizadeh
Lorna Gibson
Felicity Goodyear-Smith
Eric Green
Catherine Greeno
Brian Hall
Petra Hampel
Liisa Hantsoo
Emily Haroz
Martin Harter
Ulrich Hegerl
Leanne Hides
Stevan Hobfoll
Simone Honikman
Marie Hudson
Thomas Hyphantis
Masatoshi Inagaki
Khalida Ismail
Hong Jin Jeon
Nathalie Jetté
Mohammad Khamseh
Kim Kiely
Sebastian Kohler
Brandon Kohrt
Yunxin Kwan
Femke Lamers
María Asunción Lara
Holly Levin-Aspenson
Valéria Lino
Shen-Ing Liu
Manote Lotrakul
Sonia Loureiro
Bernd Löwe
Nagendra Luitel
Crick Lund
Ruth Ann Marrie
Laura Marsh
Brian Marx
Anthony McGuire
Sherina Mohd Sidik
Tiago Munhoz
Kumiko Muramatsu
Juliet Nakku
Laura Navarrete
Flávia Osório
Vikram Patel
Brian Pence
Philippe Persoons
Inge Petersen
Angelo Picardi
Stephanie Pugh
Terence Quinn
Elmars Rancans
Sujit Rathod
Katrin Reuter
Svenja Roch
Alasdair Rooney
Heather Rowe
Iná Santos
Miranda Schram
Juwita Shaaban
Eileen Shinn
Abbey Sidebottom
Adam Simning
Lena Spangenberg
Lesley Stafford
Sharon Sung
Keiko Suzuki
Richard Swartz
Pei Lin Lynnette Tan
Martin Taylor-Rowan
Thach Tran
Alyna Turner
Christina van der Feltz-Cornelis
Thandi van Heyningen
Henk van Weert
Lynne Wagner
Jian Li Wang
Jennifer White
Kirsty Winkley
Karen Wynter
Mitsuhiko Yamada
Qing Zhi Zeng
Yuying Zhang
Jewish General Hospital · CAMcGill University · CACharité - Universitätsmedizin Berlin · DE

Funding

Depression Screening &Treatment in Ovarian CancerK07CA093512 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHINN, EILEEN H · 2003 to 2007
$599k
CIHRNCI NIH HHS K07 CA093512
6 · The paper itself

Abstract

Importance: The Patient Health Questionnaire depression module (PHQ-9) is a 9-item self-administered instrument used for detecting depression and assessing severity of depression. The Patient Health Questionnaire-2 (PHQ-2) consists of the first 2 items of the PHQ-9 (which assess the frequency of depressed mood and anhedonia) and can be used as a first step to identify patients for evaluation with the full PHQ-9. Objective: To estimate PHQ-2 accuracy alone and combined with the PHQ-9 for detecting major depression. Data Sources: MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, PsycINFO, and Web of Science (January 2000-May 2018). Study Selection: Eligible data sets compared PHQ-2 scores with major depression diagnoses from a validated diagnostic interview. Data Extraction and Synthesis: Individual participant data were synthesized with bivariate random-effects meta-analysis to estimate pooled sensitivity and specificity of the PHQ-2 alone among studies using semistructured, fully structured, or Mini International Neuropsychiatric Interview (MINI) diagnostic interviews separately and in combination with the PHQ-9 vs the PHQ-9 alone for studies that used semistructured interviews. The PHQ-2 score ranges from 0 to 6, and the PHQ-9 score ranges from 0 to 27. Results: Individual participant data were obtained from 100 of 136 eligible studies (44 318 participants; 4572 with major depression [10%]; mean [SD] age, 49 [17] years; 59% female). Among studies that used semistructured interviews, PHQ-2 sensitivity and specificity (95% CI) were 0.91 (0.88-0.94) and 0.67 (0.64-0.71) for cutoff scores of 2 or greater and 0.72 (0.67-0.77) and 0.85 (0.83-0.87) for cutoff scores of 3 or greater. Sensitivity was significantly greater for semistructured vs fully structured interviews. Specificity was not significantly different across the types of interviews. The area under the receiver operating characteristic curve was 0.88 (0.86-0.89) for semistructured interviews, 0.82 (0.81-0.84) for fully structured interviews, and 0.87 (0.85-0.88) for the MINI. There were no significant subgroup differences. For semistructured interviews, sensitivity for PHQ-2 scores of 2 or greater followed by PHQ-9 scores of 10 or greater (0.82 [0.76-0.86]) was not significantly different than PHQ-9 scores of 10 or greater alone (0.86 [0.80-0.90]); specificity for the combination was significantly but minimally higher (0.87 [0.84-0.89] vs 0.85 [0.82-0.87]). The area under the curve was 0.90 (0.89-0.91). The combination was estimated to reduce the number of participants needing to complete the full PHQ-9 by 57% (56%-58%). Conclusions and Relevance: In an individual participant data meta-analysis of studies that compared PHQ scores with major depression diagnoses, the combination of PHQ-2 (with cutoff ≥2) followed by PHQ-9 (with cutoff ≥10) had similar sensitivity but higher specificity compared with PHQ-9 cutoff scores of 10 or greater alone. Further research is needed to understand the clinical and research value of this combined approach to screening.

Indexed as

Patient Health QuestionnaireAdultFemaleHumansInterviews as TopicMajor Depressive DisorderMaleMass ScreeningROC CurveSensitivity and Specificity

Identifiers

PMID32515813
PMCPMC7284301
OpenAlexW3033489403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.